Technical Analysis for NOTV - Inotiv, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 4.32 | -8.09% | -0.38 |
NOTV closed down 8.09 percent on Friday, April 19, 2024, on 1.34 times normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 200 DMA | Bearish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Wide Bands | Range Expansion | -8.09% | |
| Down 3 Days in a Row | Weakness | -8.09% | |
| Down 4 Days in a Row | Weakness | -8.09% | |
| Down 5 Days in a Row | Weakness | -8.09% |
| Alert | Time |
|---|---|
| 200 DMA Support | about 23 hours ago |
| 60 Minute Opening Range Breakdown | 1 day ago |
| Down 5% | 1 day ago |
| Fell Below 200 DMA | 1 day ago |
| Down 3% | 1 day ago |
Free Daily (Stock) Chart Reading
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Inotiv, Inc. is a pharmaceutical development company providing contract research services and monitoring instruments to emerging pharmaceutical companies and the world's leading drug development companies and medical research organizations. The Company focuses on developing innovative services supporting its clients’ discovery and development objectives for improved decision-making and accelerated goal attainment. The Company’s products focus on increasing efficiency, improving data, and reducing the cost of taking new drugs to market.
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Pharmaceutical Health Sciences Pharmacy Health Care Pharmacology Drug Development Pharmaceutical Sciences Contract Research Organizations Contract Research Services
Classification
Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Pharmaceutical Health Sciences Pharmacy Health Care Pharmacology Drug Development Pharmaceutical Sciences Contract Research Organizations Contract Research Services
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.4166 |
| 52 Week Low | 1.61 |
| Average Volume | 524,453 |
| 200-Day Moving Average | 4.53 |
| 50-Day Moving Average | 7.44 |
| 20-Day Moving Average | 7.83 |
| 10-Day Moving Average | 6.01 |
| Average True Range | 0.77 |
| RSI (14) | 25.37 |
| ADX | 34.35 |
| +DI | 14.64 |
| -DI | 38.30 |
| Chandelier Exit (Long, 3 ATRs) | 9.10 |
| Chandelier Exit (Short, 3 ATRs) | 6.59 |
| Upper Bollinger Bands | 12.18 |
| Lower Bollinger Band | 3.47 |
| Percent B (%b) | 0.1 |
| BandWidth | 111.26 |
| MACD Line | -0.88 |
| MACD Signal Line | -0.39 |
| MACD Histogram | -0.4938 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 5.12 | ||||
| Resistance 3 (R3) | 5.19 | 5.00 | 4.98 | ||
| Resistance 2 (R2) | 5.00 | 4.80 | 4.96 | 4.94 | |
| Resistance 1 (R1) | 4.66 | 4.67 | 4.57 | 4.59 | 4.89 |
| Pivot Point | 4.47 | 4.47 | 4.42 | 4.43 | 4.47 |
| Support 1 (S1) | 4.13 | 4.27 | 4.04 | 4.06 | 3.75 |
| Support 2 (S2) | 3.94 | 4.14 | 3.90 | 3.70 | |
| Support 3 (S3) | 3.60 | 3.94 | 3.66 | ||
| Support 4 (S4) | 3.53 |
